FY2025 Earnings Forecast for OTCMKTS:GTBIF Issued By Cormark

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Equities research analysts at Cormark dropped their FY2025 earnings estimates for Green Thumb Industries in a report issued on Monday, August 11th. Cormark analyst J. Pytlak now anticipates that the company will post earnings of $0.06 per share for the year, down from their previous estimate of $0.10. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share.

Separately, Benchmark reissued a “buy” rating on shares of Green Thumb Industries in a research report on Monday.

Green Thumb Industries Trading Up 8.9%

GTBIF opened at $8.91 on Tuesday. The company has a fifty day moving average price of $5.90 and a two-hundred day moving average price of $6.03. The company has a market cap of $1.89 billion, a P/E ratio of 81.01 and a beta of 1.18. Green Thumb Industries has a 1-year low of $4.63 and a 1-year high of $12.00.

Green Thumb Industries (OTCMKTS:GTBIF) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.05). Green Thumb Industries had a net margin of 2.51% and a return on equity of 1.62%. The company had revenue of $293.26 million during the quarter, compared to the consensus estimate of $280.66 million.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.